基于体重的阿司匹林给药方案可进一步降低初次全关节置换术后静脉血栓栓塞发生率
该回顾性观察研究纳入2403例初次全髋或膝关节置换患者,比较基于体重阿司匹林方案(体重≥120kg者325mg每日两次,<120kg者81mg每日两次,用4周)与81mg每日两次方案。
核心结论
- 基于体重阿司匹林方案较历史对照显著减少全关节置换术后VTE,6周相对风险降低69%,6个月降低62%。
- 提示决定术后阿司匹林血栓预防时需考虑患者体重。
研究设计与样本
- 单中心回顾性观察研究,纳入2403例初次全髋或膝关节置换患者。
- 基于体重阿司匹林组1247例:体重≥120kg者325mg每日两次,<120kg者81mg每日两次,均用4周;对照组1156例接受81mg每日两次。
- 术后42天和6个月通过病历回顾识别VTE和胃肠道出血事件,采用多变量逻辑回归校正协变量。
主要发现
- 全髋与全膝关节置换病例间VTE发生率无差异(P=0.8)。
关键数值与推荐
- 基于体重给药:体重≥120kg者阿司匹林325mg每日两次,体重<120kg者81mg每日两次,疗程4周。
- 对照方案:阿司匹林81mg每日两次。
临床怎么用
- 全关节置换术后阿司匹林血栓预防可考虑根据体重调整剂量,尤其体重≥120kg患者。
- 基于体重方案未增加胃肠道出血风险,但需结合患者个体情况评估。
局限性
- 回顾性观察研究,对照组为历史对照,可能存在选择偏倚和未测量混杂。
- 单中心研究,结果外推需谨慎。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Obesity poses a challenge to thromboembolic prophylaxis following total joint arthroplasty (TJA). The purpose of this study is to evaluate a weight-based aspirin dosing regimen for prevention of venous thromboembolism (VTE) following TJA. METHODS: This is a retrospective observational study of 2403 patients who underwent primary total hip or knee arthroplasty at one institution. A weight-based aspirin dosing regimen for VTE prophylaxis was administered to 1247 patients: patients weighing ≥120 kg received 325 mg aspirin twice daily (BID) and those weighing <120 kg received 81 mg aspirin BID for 4 weeks. In total, 1156 patients in the comparison cohort received 81 mg aspirin BID. VTE and gastrointestinal bleeding events were identified through chart review at 42 days and 6 months postoperatively. A multivariable logistic regression was performed to adjust for covariates. RESULTS: The weight-based aspirin cohort had a significantly lesser incidence of VTE at 42 days (P = .03, relative risk [RR] 0.31, 95% confidence interval 0.12-0.82) and 6 months (P = .03, RR 0.38, 95% confidence interval 0.18-0.80). There was no difference in VTE incidence between total hip arthroplasty and total knee arthroplasty cases (P = .8). There was no difference in gastrointestinal bleeding events between the cohorts at 42 days (P = .69) or 6 months (P = .92). Subanalysis of patients weighing ≥120 kg demonstrated a significant difference between the cohorts with a VTE incidence of 3.48% and 0% in the 81 mg and weight-based cohorts, respectively (P = .02). CONCLUSION: Patients prescribed a weight-based aspirin regimen had significantly fewer VTEs after TJA compared to historical controls with an RR reduction of 69% at 6 weeks and 62% at 6 months postoperatively. This suggests the need to factor patient weight when determining postoperative VTE prophylaxis with aspirin.
引用
- Halbur CR, Gulbrandsen TR, West CR, et al. Weight-Based Aspirin Dosing May Further Reduce the Incidence of Venous Thromboembolism Following Primary Total Joint Arthroplasty. J Arthroplasty. 2021. PMID: 34215460. doi:10.1016/j.arth.2021.06.008
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。